Status:

COMPLETED

Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

Lead Sponsor:

Assaf-Harofeh Medical Center

Conditions:

Fibromyalgia

Hyperbaric Oxygen

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover clinical trial. Th...

Detailed Description

The study will include 70 fibromyalgia patients in whom physical trauma, such mild traumatic brain injury (mTBI), could be considered as the trigger for FMS. Each participant will be examined at the t...

Eligibility Criteria

Inclusion

  • FMS diagnosis, based on the updated 2016 diagnostic criteria
  • previous physical trauma (such as traumatic brain injury)

Exclusion

  • the presence of systemic inflammatory disorders including inflammatory rheumatological and autoimmune disorders.
  • active malignancy,
  • chronic ongoing infection
  • major psychiatric disorders (excluding anxiety)
  • Patients currently or previously treated with Duloxetine (Cymbalta) or Pregabalin (Lyrica) will also be excluded
  • previous HBOT for any other reason prior to their inclusion;
  • Chest pathology incompatible with pressure changes (including active asthma);
  • Inner ear disease
  • Claustrophobia;
  • Inability to perform awake brain MRI test;
  • Previous neurologic conditions (eg. Epilepsy, neuromuscular diseases, metabolic diseases, etc.);
  • Brain tumors;
  • Skull base fractures;
  • s/p neurosurgery that included: ventricular drainage, subdural hematomas drainage, epidural hematomas drainage, intracerebral hemorrhage evacuation. Depressed fracture surgery, (Patients suffering from Encephalomalacia per MRI imaging will not be excluded).
  • Inability to provide informed consent

Key Trial Info

Start Date :

March 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2022

Estimated Enrollment :

76 Patients enrolled

Trial Details

Trial ID

NCT03325959

Start Date

March 1 2017

End Date

June 1 2022

Last Update

July 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assaf-Harofeh Medical Center

Ẕerifin, Israel, 70300

Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome | DecenTrialz